1. AHRO : Austin Health Research Online

Simon R Knight

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Simon R Knight
Full Name
Knight, Simon R
 
Department
 
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Aged
Author:  Berlangieri, Salvatore U

Results 1-4 of 4 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
11-Jul-2010Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.Barnett, Stephen A ; Baste, Jean-Marc; Murugappan, Kowsi; Tog, Check; Berlangieri, Salvatore U ; Scott, Andrew M ; Seevanayagam, Siven ; Knight, Simon R 
228-Mar-2009Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.Lee, S T; Ghanem, M; Herbertson, R A; Berlangieri, Salvatore U ; Byrne, Amanda J; Tabone, K; Mitchell, Paul L R ; Knight, Simon R ; Feigen, Malcolm; Scott, Andrew M 
321-May-2007Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M 
45-May-2005Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.Yap, Kelvin K; Byrne, Amanda J; Berlangieri, Salvatore U ; Poon, Aurora M T ; Mitchell, Paul L R ; Knight, Simon R ; Clarke, Peter C; Harris, Anthony H; Tauro, Andrew; Rowe, Christopher C ; Scott, Andrew M